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ABSTRACT
Objective: Root of Acorus calamus has been traditionally used as an anticonvulsant. The aim of the study is to assess the anticonvulsant activity of 
ethanolic extract of A. calamus (EEAC) by maximal electroshock seizure (MES) and pentylenetetrazol (PTZ)-induced seizure models on albino (Wistar 
strain) rats.
Methods: Albino rats were taken and divided into five groups, each consisting of five rats both for MES and PTZ model. One group was used as control 
(normal saline 10 ml/kg), one as standard (phenytoin in MES model/diazepam in PTZ model), and three groups for the test drug (EEAC in the doses 
of 100, 200, and 400 mg/kg). In MES model, maximal electrical shock of 150 mA was passed for 0.2 s through earlobe electrodes after 30 min of giving 
the drugs and normal saline. Different stages of convulsions were noted down along with time spent by the animal in each phase of convulsions. In 
PTZ model, PTZ was injected 30 min after giving the drugs and normal saline, and onset of action and severity of convulsions were noted. Data were 
statistically analyzed by one-way analysis of variance followed by multiple Dunnett’s test.
Results: EEAC dose dependently reduced the duration of tonic hind limb extension in MES model, and there was increase in latency and occurrence 
of convulsions in PTZ model.
Conclusion: EEAC has anticonvulsant activity.
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INTRODUCTION
Epilepsy is a disease of the brain characterized by at least two unprovoked 
(or reflex) seizures occurring more than 24 h apart [1]. In epilepsy, 
there is predisposition to generate epileptic seizures [2]. Seizures 
occur due to abnormal excessive or synchronous neuronal activity in 
the brain and are associated with alterations in electrographic pattern, 
consciousness, sensation, and behavior. Secondary epilepsy may result 
from various insults such as anorexia, trauma, tumors, metabolic 
abnormalities, neurotoxicity, drug withdrawal, and encephalitis [3].
Although lots of antiepileptic drugs are available in the market, almost 
33% of patients continue to present seizure [4]. There comes the 
importance of animal models, especially newer models that can model 
epilepsy in a more realistic way. However, there is a growing concern that 
conventional tests (maximal electroshock seizure [MES] and Sc. PTZ) 
identify only those drugs which have similar characteristics with 
existing drugs, and these methods may fail to identify agents acting by 
novel mechanisms [5].
The importance of traditional system of medicine and certain medicinal 
practices has now been recognized worldwide. Today, it is required to 
have an intelligent and pragmatic approach to evaluate selective drugs 
of herbal origin [6].
Acorus calamus is commonly known as sweet flag in English and 
vasa/bach in Hindi. A. calamus is a source of essential oil, which is 
responsible for the medicinal and insecticidal properties. It is reported 
to possess insecticidal, lucicidal, anti-inflammatory, antibacterial, 
antiulcer radioprotective, antispasmodic, bronchodilatory, glucosidase 
inhibitory, insulin sensitizing, antiepileptic, anticholinesterase, 
larvicidal, antibacterial, mutagenic, anticonvulsant, neuroleptic, smooth 
muscle relaxant, and smooth muscle stimulant activity [7].
The roots and rhizomes of this plant have been used in the Indian 
systems of medicine for 100 years. It is used in Ayurveda medicine on 
a regular basis for the treatment of insomnia, melancholia, neurosis, 
epilepsy, hysteria, loss of memory, and remittent fevers [8].
Different parts of the plant showed the presence of large number of 
phenylpropanoids, sesquiterpenes, monoterpenes, xanthone glycosides, 
flavones, lignin, lignans, steroids, and inorganic constituents. Alcoholic 
extracts of the triploid A. calamus were characterized by a higher 
percentage of beta-asarone (11%), which was the main compound [9].
A. calamus has been used for a long time in traditional medicine as a 
remedy for pain, convulsions, inflammation, and ulcer. Drugs acting 
in the central nervous system were among the first to be discovered 
by the primitive human and are still the most widely used group of 
pharmacological agents. The central nervous system (CNS) acting 
drugs are invaluable therapeutically because they can produce specific 
physiological and psychological effects. From the vast array of materia 
medica of the indigenous system so many plants have been reported to 
have activity against CNS disorders and thus act as very useful remedies 
for the alleviation of human suffering [10].
In spite of traditional use, pharmacology of its different parts has not 
yet been explored scientifically. As such, the present investigation was 
carried out to evaluate the antiepileptic activity of the ethanolic extract 
of root of A. calamus (EEAC) in experimental animal models.
METHODS
This study has been approved by IEAC, Assam Medical College, 
Dibrugarh. Certificate no. being AMC/EC/PG/2013/11718 dated 
06/09/2013.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i1.29004
Research Article
186
Asian J Pharm Clin Res, Vol 12, Issue 1, 2019, 185-188
 Kaushik and Gohain 
Plant authentication
A. calamus root was collected from the PG hostel campus of Assam 
Medical College, Dibrugarh, and identified by Dr. L.R. Saikia, Reader, 
Department of Life Sciences, Dibrugarh University, Dibrugarh, Assam, 
with identification voucher number DUL. Sc.457.
Preparation of plant extract
The required amount of root of A. calamus was collected and dried 
at room temperature. The dried roots were ground into powder 
separately. Sufficient amount of powdered roots was moistened with 
95% ethyl alcohol and allowed to remain for 6 h in a percolator. When 
the liquid began to drop from the percolator, the orifice was closed and 
the content was allowed to macerate for 24 h. After 24 h, it was allowed 
to percolate slowly, a rate not exceeding 1 ml/min and the solution was 
collected in Petri dishes. Alcohol was allowed to evaporate at room 
temperature. When the extract got completely dried, it was scrapped 
out, weighed, and stored, and the yield at the end of extraction was 
found to be 80 g [11].
Drugs
Phenytoin obtained from Zydus Cadila Healthcare Limited, Diazepam 
obtained from Ranbaxy Laboratories, New Delhi, and pentylenetetrazol 
(PTZ) obtained from Sigma-Aldrich, India, Bangalore.
Animal
Healthy Albino rats (Rattus norvegicus) weighing from 150 to 250 g 
of either sex were taken from Central Animal House, Assam Medical 
College (registration no. 634/02/a/CPCSEA dated 19/05/02). The 
animals were housed in standard cages and maintained under normal 
room temperature. The rats were maintained on standard animal diet 
of Bengal gram, wheat, maize, and carrot in sufficient quantity for the 
entire period of the experiment. Water was given ad libitum during the 
entire period of the experiment.
Acute oral toxicity studies
Acute oral toxicity test was done according to the OECD guidelines 
425 [12]. Albino rats of either sex were used. A total of five animals 
were used. After overnight fasting, they received a single oral dose 
(2000 mg/kg body weight) of EEAC. Then, food was withheld for 
further 3–4 h. Animals were observed individually at least once during 
the first 30 min after dosing, periodically during the first 24 h (with 
special attention during the first 4 h) and daily thereafter for 14 days. At 
the end of the study, the animals were observed for general toxic signs, 
morphological behavior, and mortality.
Experimental design
MES model
A total of 25 Albino rats were taken and divided into four groups, five 
rats in each and treated as follows:
1. Control - received normal saline (10 ml/kg) intraperitoneal (i.p.)
2. Test 1 - received EEAC 100 mg/kg i.p.
3. Test 2 - received EEAC 200 mg/kg i.p.
4. Test 3 - received EEAC 400 mg/kg i.p.
5. Standard drug - received phenytoin 25 mg/kg i.p. [13]
Each animal was properly held and earlobe electrodes were placed 
on the earlobes and current of 150 mA was passed for 0.2 s. Different 
stages of convulsions were noted down, along with the time spent 
by the animal in each phase. The same procedure was repeated with 
other animals of control group. The current was passed 30 min after 
i.p. injection of normal saline. For test groups, the same procedure was 
repeated for three different doses (100, 200, and 400 mg/kg) of EEAC.
Phenytoin was also injected i.p. to all the five rats. After 30 min, the 
animals were subjected to electroconvulsions.
This model identifies those compounds, which prevent seizure 
spread [14].
The reduction in time or abolition of tonic extensor phase of 
MES - convulsions was recorded for all the animals [15].
PTZ model
It is reported to act through benzodiazepine receptor mechanisms in 
the brain.
A total of 25 albino rats were taken and divided into four groups, five 
rats in each and treated as follows:
1. Control - received normal saline (10 ml/kg) i.p.
2. Test 1 - received EEAC 100 mg/kg i.p.
3. Test 2 - received EEAC 200 mg/kg i.p.
4. Test 3 - received EEAC 400 mg/kg i.p.
5. Standard drug - received diazepam 4 mg/kg i.p.
Normal saline, test drugs, and diazepam were injected i.p. to the animals, 
and after 30 min, PTZ (60 mg/kg) [16] was injected subcutaneously to 
these animals and the onset of action (indicated by Straub’s tail, jerky 
movements of whole body and convulsions) and severity of convulsions 
due to the drug were noted.
Either delay or complete abolition of convulsions in rats treated with 
diazepam and EEAC was noted [17].
Statistical analysis
The statistical significance between groups was analyzed separately 
using one-way analysis of variance (ANOVA) followed by Dunnett’s 
multiple comparison test. The statistical significance was expressed 
by p values, as mentioned in the tables. p<0.05 was considered as 
statistically significant.
RESULTS
Acute toxicity test- there was no mortality and no signs-symptoms of 
toxicity reported among the animals up to 2000 mg/kg. Hence, the LD50 
was calculated >2000 mg/kg body weight.
In MES model, although the test groups did not abolish the extensor 
phase completely like phenytoin, there was significant (<0.01) 
reduction in the duration of the tonic hind limb extensor phase in a 
dose-dependent manner. All the rats under the study recovered without 
any deaths [Table 1].
Table 1: Effect of EEAC on extensor phase of convulsion induced by MES model in albino rats
Group Treatment (mg/kg) Number of rats Hind limb extension (seconds±SEM) Recovery
Control Normal saline 10 ml/kg 5 11.87±0.38 R
Test 1 EEAC 100 5 5.26±0.16a R
Test 2 EEAC 200 5 3.94±0.018a R
Test 3 EEAC 400 5 2.14±0.108a R







n=5 in each group; all the values were expressed in mean±SEM. ap<0.01 is significant when compared with control (ANOVA followed by Dunnett’s multiple comparison 
test), EEAC: Ethanolic extract of A. calamus, MES: Maximal electroshock seizure, Acorus calamus: A. calamus
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In PTZ model, there was increase in the latency to the occurrence of 
convulsions in the three test groups (100, 200, and 400 mg/kg) of EEAC 
as compared to the control group, but it did not abolish the convulsions 
completely as was seen with the standard group of diazepam (4 mg/kg), 
but the increase in the latency was highly significant (<0.01) in a dose-
dependent manner [Table 2].
All the animals recovered from the convulsions after the test and there 
were no deaths in any of the groups.
DISCUSSION
The present study was undertaken to evaluate the anticonvulsant 
activity of the EEAC in experimental animal models.
The following experimental designs were selected.
1. MES model
2. PTZ-induced seizure model.
The MES-induced convulsions for the screening of the anticonvulsant 
drug are the standard experimental model for evaluating a drug in 
experimental animals for its anticonvulsant property, which represents 
grand mal epilepsy in human beings.
The anticonvulsant effect by the MES model is determined by the effect 
of the drug in the tonic hind limb extensor phase of the convulsion, 
by either completely abolishing it or by reducing its duration. In the 
present study, it was found that the duration of the extensor phase in 
the test groups was reduced.
There was complete abolition of extensor phase in the standard group of 
phenytoin. Phenytoin sodium exerts antiepileptic effect by stabilization 
of neuronal membrane and thus prolongation of recovery of inactivated 
sodium channels. In high doses, phenytoin can also block the calcium 
influx during depolarization [18].
From the above findings, it can be said that the EEAC reduced the 
extensor phase of convulsion in a dose-dependent manner.
The seizure produced by the PTZ-induced seizure model resemble 
to the absence or petit mal seizure in human beings. A drug, which 
causes either delay or complete abolition of convulsions in the PTZ-
induced seizure model, is said to have got anticonvulsant activity. It is 
reported to act through benzodiazepine receptor mechanisms in the 
brain.
In the present study, latency to convulsion increases in the test groups 
with increasing doses. In the standard group of diazepam (4 mg/kg), 
there was complete absence of convulsions within the specified time of 
60 min of observation after subcutaneous PTZ injection. Furthermore, 
the average duration of convulsions was decreased in test groups with 
increasing dose.
CONCLUSION
From the above two seizure models of MES and PTZ, it can be concluded 
that EEAC has got anticonvulsant effect in a dose-dependent manner.
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